Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Keith Feral who wrote (357)	12/10/2007 12:56:32 PM
From: Keith Feral	Read Replies (1) of 370

The company seemed to think they could file an NDA in 2008 with the results from the phase 2 trial. They also said they were waiting to hear back from the FDA about the conclusions from the DSMB. 35% response rate looked good, with 93 % of the people responding to the initial infusion. The stock is trading at 1 times cash, which gives the shares some room for upside. I flipped my shares this morning. The company has almost no coverage, only 1 analyst bothered to ask a question during the Q & A. They said they talked to "potential partners" at the conference this weekend. A parternship would certainly give them more room for upside.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next